A positive drug test can be powerful evidence but the result must be reliably linked to the person charged. In this case, uncertainty over which person supplied the tested sample, led to an acquittal.
Key takeaways
- The dispute concerned whose sample was tested, rather than whether the laboratory detected cannabis. The documents left the court unable to attribute the positive result confidently to the defendant.
- Two positive reports did not resolve the problem because both relied on the same disputed sample. Neither provided independent confirmation from a separately identified sample.
- A paperwork discrepancy does not automatically defeat a prosecution. Its effect depends on whether the records, considered together, reliably connect the sample to the accused.
Case Background and Court Findings
The case began after an accident, when urine samples were taken from two different people. Both samples were sent for testing, and one of the individuals was subsequently charged with using cannabis. The Public Prosecution relied on two reports, one from forensic medicine and another from the criminal laboratory, recording the presence of the drug in the sample attributed to him. He denied using cannabis during the investigation and before the court. Nevertheless, the Court of First Instance convicted him and imposed imprisonment and deportation.
The defendant appealed. When the Court of Appeal examined the documents, it identified a problem with the way the samples had been submitted. Two official covering letters concerned different individuals, yet both carried the same reference number and date. The court could not identify a separate exhibit number that reliably distinguished one sample from the other. An exhibit number is used to identify the container holding the sample and connect it to the person from whom it was collected.
The defense was not arguing that the laboratory had failed to identify cannabis correctly. Its objection was that the positive sample might not belong to the defendant at all. The court therefore had to establish whether the documents reliably connected the tested container to this particular individual. A positive result does not answer that question if the records identifying and accompanying the samples leave a genuine possibility that they were confused.
The documents also showed that the other individual had previous drug convictions and was subject to periodic testing. The court considered this information among the circumstances surrounding the possible mix-up. However, it did not decide that the positive sample definitely belonged to that other person. Nor did it need to determine his guilt. Its task was to assess whether the sample had been reliably attributed to the defendant whose case it was deciding.
The court then examined the two reports relied on by the prosecution. A forensic medicine report and a criminal laboratory report might initially appear to provide two separate sources of confirmation. In this case, however, both reports depended on the same sample. The documents did not show that the forensic medicine report relied on a separate sample independently collected from the defendant. The uncertainty about the sample’s identity therefore affected both reports, even though the result appeared in more than one document.
The court also reviewed a later letter in the file confirming that the forensic medicine report relied on the disputed sample. It did not simply assume that the reports shared a source because their findings were similar. It based that conclusion on correspondence explaining what had actually been examined.
This mattered to the outcome. Had there been another sample reliably linked to the defendant, the court would have needed to assess its result as separate evidence. In the case before it, the source remained the same disputed sample. The court also found no other evidence sufficient to establish drug use. The defendant maintained his denial, while the scientific evidence continued to depend on a container the court could not confidently connect to him.
The Court of Appeal overturned the conviction and acquitted the defendant. The Public Prosecution challenged the acquittal before the Court of Cassation. Its objection was specific: although the covering letters carried the same reference number and date, each sample bore its owner’s name. The prosecution argued that those names adequately distinguished the samples and that the similarity in the correspondence should not have resulted in an acquittal.
The Court of Cassation rejected that argument. It found that the appeal court had examined the documents, considered the evidence and explained why it was not satisfied that the sample belonged to the defendant. The acquittal did not rest on an unexplained expression of doubt. Its reasons identified the matching correspondence, the lack of adequate differentiation between the samples, the reports’ reliance on the same source and the absence of other supporting evidence. The prosecution’s challenge was rejected, leaving the acquittal in place.
The reason for the acquittal was straightforward: the court was not sufficiently satisfied that the positive sample belonged to the defendant. It did not find that the laboratory had invented the result or that an employee had deliberately exchanged the containers. It did not even need to establish that an exchange had definitely occurred. The possibility of confusion arising from the documents was sufficiently serious to prevent reliance on the evidence, and the remaining records did not resolve it.
This does not mean that a repeated reference number always leads to an acquittal. A number may identify an incident involving several people, while other records clearly distinguish each sample. A laboratory receipt or evidence-handling record may explain how every container remained connected to its owner. In those circumstances, the court may accept the result. The decision in this case depended on the documents considered together, rather than on an isolated clerical mistake.
In a similar case, the relevant documents would include the sample collection record, the container’s identifying details, the covering letter, the laboratory receipt and the reference appearing in the final report. Comparing them helps establish whether they consistently refer to the same sample. Any material discrepancy can then be put to the appropriate authority for an explanation. This produces a focused objection: a particular inconsistency in particular documents, with a clear explanation of how it affects attribution of the result.
The purpose of any request for further testing also needs to be clear. Testing the same container again may confirm that it contains cannabis, but it does not establish who supplied the sample. Where identity is disputed, the immediate issue is the documentation linking the sample to the defendant. That explains the outcome here: the conviction was overturned despite two positive reports because neither report resolved the uncertainty about whether the tested sample belonged to the person on trial.
Conclusion
The case turns on a simple evidential question: did the tested sample belong to the defendant? The court found that the documents did not answer it reliably, and the two reports could not cure that gap because they came from the same sample.
Frequently asked questions
1. Can a positive drug test be challenged in court?
Yes. The challenge may be to the test itself, or to the records that link the sample to the person tested. The point raised must be supported in a specific issue in the evidence.
2. What documents matter when the identity of a sample is disputed?
The collection record, container label, transfer records, laboratory receipt and final report can help trace a sample. Reading them together may reveal whether the identifying details remain consistent.
3. Does an error in a laboratory form automatically invalidate the result?
No. The court may look at other records to see if the error can be explained and the sample can still be identified. The significance of a discrepancy lies within the framework of the whole of the evidence.
4. Would repeating the laboratory test settle a dispute over sample identity?
A repeat test can verify what is in the container. If the uncertainty arose during the collection, or handling, it may not identify who provided the sample.
5. What if a prescribed medicine could explain a positive result?
The person should identify the medicine and provide the prescription and treatment records for assessment. That raises a different question from sample identity: whether the detected substance can be explained by documented medical treatment under the applicable law.
Related Links
About the Author
Dr. Hassan Elhais publishes analysis of UAE criminal law matters, including drug-related allegations and the legal questions arising in narcotics matters. For readers researching a drug case lawyer in Dubai, his writing offers insight into the legal questions surrounding these topics. Explore his published work and practice-area information for further context.
Copyright © of this article is retained by the author and/or other copyright owners. We explicitly grant you permission to download a copy, without any alteration, of this article
for personal non-commercial research or study, without prior permission or any charge. This article can be utilized on your website or for marketing, however, we grant you permission
to host this article on your website and no other rights. This content should not be altered in any way or sold commercially in any format without prior permission of the copyright holder.
During reference of this article, full biographic details entailing the name of the author, his designation, the institute and the publishing date of the article shall be provided.
